Literature DB >> 15988630

Development of panel of monoclonal antibodies specific to urochordate cell surface antigens.

Ziva Lapidot1, Baruch Rinkevich.   

Abstract

Monoclonal antibodies are an important tool in the study of botryllid ascidians' immunology and developmental biology. Here we describe the development of a panel of 38 monoclonal antibodies that are specific to Botryllus schlosseri (Ascidiacea; subfamily Botryllinae) cell surface antigens. Many of these hybridomas recognize (by enzyme-linked immunosorbent assay and immunohistochemistry) epitopes of Botrylloides subpopulations (SP) II and III from the Mediterranean coast of Israel and show, on blood cell smear assays, reactions with subsets of Botryllus circulating blood cells. Fluorescence-activated cell sorting analyses using antibodies positive for botryllid tissues revealed up to 3.6% positive cells. ELISA screenings were performed with 64 new monoclonal antibodies on 5 different individual botryllid ascidian colonies (B. schlosseri, Botrylloides). The positive antibodies in this panel identified a large number of different antigenic determinants, some of which distinguish Botryllus versus Botrylloides colonies, and other, different colonies within these two species, or different cell types within tissues, embryos, and buds of individual colonies. Only 21 monoclonal antibodies tested positive with all colonies. Cross-reactivity with at least one Botrylloides colony was recorded in 49 hybridomas that identified Botryllus cells. This wide panel of monoclonal antibodies is the first such detailed set of monoclonals available for studies on botryllid ascidians.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988630     DOI: 10.1007/s10126-004-5067-9

Source DB:  PubMed          Journal:  Mar Biotechnol (NY)        ISSN: 1436-2228            Impact factor:   3.619


  13 in total

1.  Monoclonal antibody specific to urochordate Botryllus schlosseri pyloric gland.

Authors:  Ziva Lapidot; Guy Paz; Baruch Rinkevich
Journal:  Mar Biotechnol (NY)       Date:  2003 Jul-Aug       Impact factor: 3.619

2.  Characterization of a polymorphic protein localized to vascular epithelium in Botryllus schlosseri: role in tunic synthesis?

Authors:  M B Fagan; I L Weissman
Journal:  Mol Mar Biol Biotechnol       Date:  1998-09

3.  A morphological and immunohistochemical study of programmed cell death in Botryllus schlosseri (Tunicata, Ascidiacea).

Authors:  R J Lauzon; C W Patton; I L Weissman
Journal:  Cell Tissue Res       Date:  1993-04       Impact factor: 5.249

4.  Degenerative regression of the digestive tract in the colonial ascidian Botryllus schlosseri (Pallas).

Authors:  P Burighel; A Schiavinato
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

5.  Separation and labeling of specific subpopulations of Botryllus blood cells.

Authors:  J M Schlumpberger; I L Weissman; V L Scofield
Journal:  J Exp Zool       Date:  1984-03

6.  Use of enzyme-linked immunosorbent assays (ELISA) for detection of monoclonal antibodies: experience with antigens of Toxoplasma gondii.

Authors:  Y Naot; J S Remington
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

7.  Protochordate allorecognition is controlled by a MHC-like gene system.

Authors:  V L Scofield; J M Schlumpberger; L A West; I L Weissman
Journal:  Nature       Date:  1982-02-11       Impact factor: 49.962

Review 8.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  A cyclical, developmentally-regulated death phenomenon in a colonial urochordate.

Authors:  R J Lauzon; K J Ishizuka; I L Weissman
Journal:  Dev Dyn       Date:  1992-05       Impact factor: 3.780

Review 10.  The colonial urochordate Botryllus schlosseri: from stem cells and natural tissue transplantation to issues in evolutionary ecology.

Authors:  Baruch Rinkevich
Journal:  Bioessays       Date:  2002-08       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.